Citigroup Adjusts Price Target on Becton Dickinson and Co. to $208 From $204, Maintains Buy Rating
Citigroup has raised its price target for Becton Dickinson and Co. (BDX) from $204 to $208, while reiterating a Buy rating on the stock. This adjustment reflects an updated outlook by the analyst firm on the medical technology company. The article also provides a …